HIV Infections Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
PD-1 Inhibition to Determine CNS Reservoir of HIV-Infection
Recruiting
  • HIV Infections
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
N
PET Imaging of the Dopaminergic and Serotonergic Systems in Treated HIV Positive Subjects - 2022
Completed
  • Depression
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
U
Reducing Disparities in Rural HIV Prevention
Recruiting
  • HIV Infections
  • Sexually Transmitted Infections
  • Virtual clinical visits with home lab kits and mailed HIV PrEP
  • Aurora, Colorado
    University of Colorado Hospital
2022-04-05
Apr 5, 2022
F
Tailored Motivational Interviewing Implementation-Effectiveness Trial in Multidisciplinary Adolescent HIV Care Settings - 2021
Completed
  • HIV Infections
  • +4 more
  • Competency: 12-Item Motivational Interviewing (MI) Coach Rating Scale (CRS)
  • +2 more
  • Detroit, Michigan
    Wayne State University
2022-04-05
Apr 5, 2022
N
Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of the Monoclonal Antibody PGT121.414.LS Administered Alone and in Combination With VRC07-523LS Via Intravenous or Subcutaneous Infusions in Healthy, HIV-uninfected Adult Participants
Active, not recruiting
  • HIV Infections
  • PGT121.414.LS
  • VRC07-523LS
  • Los Angeles, California
  • +4 more
2022-04-05
Apr 5, 2022
V
An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 2) - 2022
Completed
Has Results
  • Infection, Human Immunodeficiency Virus
  • HIV Infections
  • Dolutegravir (DTG)
  • +2 more
  • Birmingham, Alabama
  • +104 more
2022-03-24
Mar 24, 2022
A
Large Scale Transition to a Dolutegravir-based First-line ART in the South: Virological Response and Impact on HIV Drug Resistance in a Real Life Context (DoReaL Study)
Not yet recruiting
  • HIV Infections
    • Abidjan, Côte D'Ivoire
    • +2 more
    2022-03-28
    Mar 28, 2022
    M
    Lipid Profile and Diabetes Mellitus in People With HIV
    Recruiting
    • HIV Infections
    • +3 more
      • Vienna, Austria
        Schalk:Pichler Gruppenpraxis
      2022-04-04
      Apr 4, 2022
      C
      Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of Concern
      Recruiting
      • SARS-CoV-2 Infection
      • +2 more
      • Moderna mRNA-1273
      • +2 more
      • Gaborone, Botswana
      • +53 more
      2022-03-25
      Mar 25, 2022
      N
      Adherence Connection for Counseling, Education, and Support (ACCESS) II
      Recruiting
      • HIV Infections
      • ACCESS II mHealth Intervention
      • ACCESS II control condition
      • Bronx, New York
        Jacobi Medical Center
      2022-03-24
      Mar 24, 2022
      U
      Evaluating the Impact of Computer-assisted X-ray Diagnosis and Other Triage Tools to Optimise Xpert Orientated Community-based Active Case Finding for TB and COVID-19
      Recruiting
      • Tuberculosis
      • +2 more
      • CAD
      • Xpert
      • Cape Town, Western Cape, South Africa
      • +2 more
      2022-03-25
      Mar 25, 2022
      F
      Development of Ingestible Biosensors to Enhance PrEP Adherence in Substance Users (PrEPSteps)
      Recruiting
      • HIV Infections
      • Substance Use Disorders
      • PrEPsteps
      • +2 more
      • Boylston, Massachusetts
        Fenway Health
      2022-03-31
      Mar 31, 2022
      V
      Regimen Switch to Dolutegravir/Lamivudine Fixed Dose Combination From Current Antiretroviral Regimen in HIV-1 Infected and Virologically Suppressed Adults (SALSA)
      Active, not recruiting
      • HIV Infections
      • Los Angeles, California
      • +118 more
      2022-04-01
      Apr 1, 2022
      V
      Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
      Not yet recruiting
      • Microtia
      • +4 more
      • Probiotic
      • Placebo
      • (no location specified)
      2022-03-21
      Mar 21, 2022
      G
      Leaving Nobody Out
      Not yet recruiting
      • HIV Infections
        • (no location specified)
        2022-03-23
        Mar 23, 2022
        I
        MOVIDA 1 Ter - Evaluation of the Cobas® Plasma Separation Card in the Field in Vietnam
        Not yet recruiting
        • HIV Infections
        • Blood sampling
        • (no location specified)
        2022-03-21
        Mar 21, 2022
        U
        Integrating Enhanced HIV PrEP Into a STI Clinic in Lilongwe
        Recruiting
        • HIV Infections
        • +11 more
        • Lilongwe, Malawi
          Bwaila STI clinic
        2022-03-24
        Mar 24, 2022
        V
        A Clinical Trial of GSK3640254 + Dolutegravir (DTG) in Human Immunodeficiency Virus-1 Infected Treatment-naive Adults
        Recruiting
        • HIV Infections
        • Bakersfield, California
        • +66 more
        2022-03-29
        Mar 29, 2022
        U
        Kuwa Free! - Live Free!
        Recruiting
        • HIV Infections
        • +2 more
        • Cabotegravir/ Rilpivirine
        • +4 more
        • Eldoret, Kenya
          Academic Model Providing Access to Healthcare (AMPATH) Moi Teach
        2022-03-30
        Mar 30, 2022
        V
        Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of Cabotegravir (CAB) 400 Milligrams Per Milliliter (mg/mL) Formulation in Healthy Adult Participants
        Recruiting
        • HIV Infections
        • Cabotegravir sodium (Oral Lead In)
        • +6 more
        • Orlando, Florida
        • +4 more
        2022-03-29
        Mar 29, 2022
        F
        Dolutegravir and Clinical Outcomes Among ART-recipients in Brazil
        Recruiting
        • HIV Infections
        • +3 more
        • No intervention
        • Salvador, Bahia, Brazil
        • +2 more
        2022-03-15
        Mar 15, 2022
        H
        Evolution of HIV Reservoir, Inflammation and Microbiota Footprint of PLWH Switching to Long-acting Injectable Treatment Compared to Patients on Oral Dual or Triple Anti-integrase-based Therapy: a Prospective Longitudinal Comparative Study
        Not yet recruiting
        • HIV Infections
        • Stool sampling
        • Blood plasma collection
        • Marseille, France
          Hôpital Européen Marseille
        2022-03-21
        Mar 21, 2022
        V
        A Study to Evaluate the Antiviral Effect, Safety and Tolerability of GSK3810109A in Viremic Human Immunodeficiency Virus (HIV)-1 Infected Adults
        Recruiting
        • HIV Infections
        • GSK3810109A
        • Long Beach, California
        • +19 more
        2022-03-29
        Mar 29, 2022
        V
        A Dose-Range Finding Clinical Trial Study in Human Immunodeficiency Virus (HIV-1) Infected Treatment-Naive Adults
        Recruiting
        • HIV Infections
        • Los Angeles, California
        • +71 more
        2022-03-29
        Mar 29, 2022
        V
        Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults
        Active, not recruiting
        Has Results
        • Infection, Human Immunodeficiency Virus
        • HIV Infections
        • Cabotegravir (CAB) tablet
        • +4 more
        • Birmingham, Alabama
        • +114 more
        2022-03-29
        Mar 29, 2022